- Home
- ICMB vs VNRX Comparison
ICMB vs VNRX Comparison
Compare ICMB & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- VNRX
- Stock Information
- Founded
- ICMB 2012
- VNRX N/A
- Country
- ICMB United States
- VNRX United States
- Employees
- ICMB N/A
- VNRX N/A
- Industry
- ICMB Finance: Consumer Services
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ICMB Finance
- VNRX Health Care
- Exchange
- ICMB Nasdaq
- VNRX Nasdaq
- Market Cap
- ICMB 41.1M
- VNRX 45.2M
- IPO Year
- ICMB N/A
- VNRX N/A
- Fundamental
- Price
- ICMB $2.78
- VNRX $0.50
- Analyst Decision
- ICMB
- VNRX Strong Buy
- Analyst Count
- ICMB 0
- VNRX 5
- Target Price
- ICMB N/A
- VNRX $3.75
- AVG Volume (30 Days)
- ICMB 54.5K
- VNRX 167.9K
- Earning Date
- ICMB 05-20-2025
- VNRX 05-20-2025
- Dividend Yield
- ICMB 17.14%
- VNRX N/A
- EPS Growth
- ICMB N/A
- VNRX N/A
- EPS
- ICMB 0.45
- VNRX N/A
- Revenue
- ICMB $23,360,165.00
- VNRX $1,233,511.00
- Revenue This Year
- ICMB N/A
- VNRX $563.72
- Revenue Next Year
- ICMB N/A
- VNRX $160.43
- P/E Ratio
- ICMB $6.20
- VNRX N/A
- Revenue Growth
- ICMB N/A
- VNRX 59.10
- 52 Week Low
- ICMB $2.46
- VNRX $0.42
- 52 Week High
- ICMB $3.67
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- ICMB 42.05
- VNRX 47.94
- Support Level
- ICMB $2.75
- VNRX $0.46
- Resistance Level
- ICMB $2.87
- VNRX $0.54
- Average True Range (ATR)
- ICMB 0.10
- VNRX 0.04
- MACD
- ICMB -0.00
- VNRX 0.01
- Stochastic Oscillator
- ICMB 16.67
- VNRX 48.00
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.